Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation of red blood cells with a modified level of blood group antigen expression and their use in the quality control of blood typing reagents

A technology for red blood cells and antigens, applied in the field of cells with altered blood group antigen expression levels, and can solve problems such as inability to detect

Inactive Publication Date: 2006-03-22
KODE BIOTECH
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

When this reagent deteriorates, red blood cells of subtypes with antigen expression levels at the low end of the acceptable range cannot be detected

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0133] Decreased Expression Level of Antigen B Acted by α-Galactosidase

[0134] 10 units of α-galactosidase extracted from green coffee beans were purchased from Glyko (Cat. No. X-5001).

[0135] 100 microliters of erythrocytes of blood type AB were washed three times with phosphate buffered saline (PBS).

[0136] Control response (ctrl):

[0137] Fifty microliters of encapsulated erythrocytes were added to 40 microliters of 100 mM citrate buffer pH 6.5 and 22.5 microliters of 500 mM citrate buffer pH 6.5.

[0138] Enzymatic reaction (enz):

[0139] Add 50 µl of encapsulated cells to 40 µl of 4 units of α-galactosidase in 100 mM pH 6.5 citrate buffer and 22.5 µl of 500 mM pH 6.5 citrate buffer in the liquid.

[0140] The mixture was reacted in a 37°C water bath with occasional mixing. The end times of the reactions were 6 hours and 9 hours, respectively, and the method of stopping was to remove the equivalent of 15 microliters of packed red blood cells, and wash the ce...

Embodiment 2

[0148] Decreased Expression Level of Antigen A Acted by α-N-acetylgalactosaminidase

[0149] α-N-acetylgalactosaminidase (Cat. No. X-5001) was purchased from Glyco.

[0150] 100 microliters of erythrocytes of blood type AB were washed three times with phosphate buffered saline (PBS).

[0151] Control response (ctrl):

[0152]6 microliters of encapsulated erythrocytes were added to 100 microliters of 100 mM citrate buffer pH 4 and 26.5 microliters of 500 mM citrate buffer pH 6.5.

[0153] Enzymatic reaction (enz):

[0154] Add 6 µl of encapsulated cells to 100 µl of 100 milliunits (mU) of α-N-acetylgalactosaminidase in 100 mM pH 4 citrate buffer and 26.5 µl of 500 mM pH 6.5 in citrate buffer.

[0155] The mixture was reacted in a 37°C water bath with occasional mixing. The end time of the reaction is 6 hours, 12 hours and 24 hours respectively, and the method of stopping is to take out 2 microliters of wrapped red blood cells and add them to 100 microliters of CelStab re...

Embodiment 3

[0167] Process for the preparation of alpha-galactosidase from coffee beans.

[0168] α-Galactosidase was extracted from green coffee beans (Coffea mesocarpus) according to the method of Courtois and Petek. (Courtois, J.E. and Petek, J., α-Galactosidase from Coffee Beans, (1996) Methods of Enzymology, 8:565-571).

[0169] The extracted enzyme was concentrated to a centrifugal ultrafiltration device (Millipore) and dialyzed against citrate phosphate buffer (100 mM, pH 6.0). The activity of the crude enzyme extract does not need to be determined. The total protein concentration was 96 mg / ml.

[0170] Enzymatic approach to reduce expression of B antigen

[0171] Control response (ctrl):

[0172] Washed and wrapped red blood cells (300 μl) of blood type AB were added to Eppendorf centrifuge tubes filled with citrate phosphate buffer (500 μl, 100 mM, pH 6.0 and 200 μl, 500 mM, pH 6.0) middle.

[0173] Enzymatic reaction (enz):

[0174] Washed and wrapped red blood cells ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention is a method of preparing the red corpuscle of low-expression blood group antigen adopting at least one immunodominant glucoamylase, such as N-acetylgalactosaminase or Alpha-galactosidase. The antigen expressed by the red corpuscle which is prepared by the method only reaches the threshold value of the antigen level that can be detected at clinic substantively. The red corpuscle prepared by this process can be applied to the quality control of the blood group reagent and the adjustment of the testing system, therefore can judge the blood group accurately and standardly.

Description

technical field [0001] The invention relates to cells with altered expression levels of blood group antigens. In particular, the invention relates to the preparation of these cells and their use in the quality control of blood typing reagents and the calibration and validation of hematological, immunohematological and immunological assays. Background technique [0002] The function of a blood center is to test blood to accurately determine an individual's blood type. Accurate and precise determination of blood type is necessary for a number of treatments, including blood transfusions, organ transplants and treatment of hereditary hemolysis in newborns. [0003] For example, a patient must know his or her blood type before receiving a blood transfusion. A mismatch between the blood type of the donor and the recipient will have serious consequences, even leading to the death of the recipient. [0004] In blood transfusion serology, ABO blood group classification is the most...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12S3/22C12N5/06C12N5/08C12N5/078
Inventor 斯蒂芬·迈克尔·亨利丽莎·格威妮丝·吉利佛
Owner KODE BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com